JPMorgan Chase & Co. Has Lowered Expectations for Spire Healthcare Group (LON:SPI) Stock Price

Key Points

• JPMorgan Chase & Co. has lowered its price target for Spire Healthcare Group from GBX 309 to GBX 303, while maintaining an "overweight" rating.
• Berenberg Bank also reaffirmed a "buy" rating on Spire Healthcare, setting a price target of GBX 280.
• Spire Healthcare's stock opened at GBX 207.65, indicating a potential upside of 45.92% from JPMorgan's revised target.

Spire Healthcare Group (LON:SPI - Get Free Report) had its price objective reduced by equities researchers at JPMorgan Chase & Co. from GBX 309 ($4.16) to GBX 303 ($4.07) in a note issued to investors on Tuesday, MarketBeat.com reports. The firm currently has an "overweight" rating on the stock. JPMorgan Chase & Co.'s price target indicates a potential upside of 42.25% from the company's current price.

Separately, Berenberg Bank reiterated a "buy" rating and issued a GBX 280 ($3.77) target price on shares of Spire Healthcare Group in a research note on Thursday, July 31st.

Spire Healthcare Group Trading Up 2.4%

SPI stock traded up GBX 5 ($0.07) during trading on Tuesday, reaching GBX 213 ($2.86). 774,045 shares of the stock traded hands, compared to its average volume of 1,336,417. The business's 50 day moving average price is GBX 216.60 and its 200-day moving average price is GBX 206.09. Spire Healthcare Group has a 52-week low of GBX 168.20 ($2.26) and a 52-week high of GBX 260.50 ($3.50). The company has a debt-to-equity ratio of 62.25, a current ratio of 0.70 and a quick ratio of 0.74. The firm has a market capitalization of £855.34 million, a PE ratio of 30.32, a P/E/G ratio of 1.06 and a beta of 0.96.

Spire Healthcare Group (LON:SPI - Get Free Report) last issued its earnings results on Thursday, July 31st. The company reported GBX 4.10 ($0.06) earnings per share (EPS) for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. As a group, sell-side analysts forecast that Spire Healthcare Group will post 15.6634747 earnings per share for the current year.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.